Analgesic agents without gastric damage: Design and synthesis of structurally simple Benzenesulfonanilide (cas 1678-25-7)-type cyclooxygenase-1-selective inhibitors

Add time:09/26/2019    Source:sciencedirect.com

In order to create novel analgesic agents without gastric disturbance, structurally simple cyclooxygenase-1 (COX-1) inhibitors with a benzenesulfonanilide skeleton were designed and synthesized. As a result, compounds 11f and 15a, which possess a p-amino group on the benzenesulfonyl moiety and p-chloro group on the anilino moiety, showed COX-1-selective inhibition. Moreover compound 11f, which is the most potent compound in this study showed more potent analgesic activity than that of aspirin at 30 mg/kg by po. The anti-inflammatory activity and gastric damage, however, were very weak or not detectably different from aspirin. Since the structure of our COX-1 inhibitors are very simple, they may be useful as lead compounds for superior COX-1 inhibitors as analgesic agents without gastric disturbance.

We also recommend Trading Suppliers and Manufacturers of Benzenesulfonanilide (cas 1678-25-7). Pls Click Website Link as below: cas 1678-25-7 suppliers

Prev:Design and synthesis of Benzenesulfonanilide (cas 1678-25-7)s active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus
Next:Research ArticlesEffect of the oral absorption of Benzenesulfonanilide (cas 1678-25-7)-type cyclooxygenase-1 inhibitors on analgesic action and gastric ulcer formation)